Persistence, Dosing, and Other Treatment Patterns Among Crohn’s Disease Patients Initiating Biologics in United States

por Teeple, Amanda, Sah, Janvi, Mallampati, Rajesh, Adams, Christopher, Waters, Dexter, Muser, Erik
Publicado 2021

Evaluating the Effect of Standard of Care Treatment on Burden of Chronic Hepatitis B: A Retrospective Analysis of the United States Veterans Population

por Sbarigia, Urbano, Kariburyo, Furaha, Sah, Janvi, Colasurdo, Jamie, Xie, Lin, Katz, Eva G., Sylvester, Shirley
Publicado 2020

Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity

por Cohen, Alexander, Sah, Janvi, Lee, Theodore, Rosenblatt, Lisa, Hlavacek, Patrick, Emir, Birol, Keshishian, Allison, Yuce, Huseyin, Luo, Xuemei
Publicado 2021

Treatment patterns and survival in metastatic castration‐sensitive prostate cancer in the US Veterans Health Administration

por Freedland, Stephen J., Sandin, Rickard, Sah, Janvi, Emir, Birol, Mu, Qiao, Ratiu, Anna, Hong, Agnes, Serfass, Lucile, Tagawa, Scott T.
Publicado 2021

Effectiveness and Safety of Apixaban, Low-Molecular-Weight Heparin, and Warfarin among Venous Thromboembolism Patients with Active Cancer: A U.S. Claims Data Analysis

por Cohen, Alexander, Keshishian, Allison, Lee, Theodore, Wygant, Gail, Rosenblatt, Lisa, Hlavacek, Patrick, Mardekian, Jack, Wiederkehr, Daniel, Sah, Janvi, Luo, Xuemei
Publicado 2021

Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic Status

por Cohen, Alexander T., Sah, Janvi, Dhamane, Amol D., Lee, Theodore, Rosenblatt, Lisa, Hlavacek, Patrick, Emir, Birol, Keshishian, Allison, Yuce, Huseyin, Luo, Xuemei
Publicado 2021

Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease

por Cohen, Alexander T., Sah, Janvi, Dhamane, Amol D., Lee, Theodore, Rosenblatt, Lisa, Hlavacek, Patrick, Emir, Birol, Delinger, Rachel, Yuce, Huseyin, Luo, Xuemei
Publicado 2021

Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding

por Cohen, Alexander T., Sah, Janvi, Dhamane, Amol D., Lee, Theodore, Rosenblatt, Lisa, Hlavacek, Patrick, Emir, Birol, Keshishian, Allison, Yuce, Huseyin, Luo, Xuemei
Publicado 2022

Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences

por Cohen, Alexander T., Sah, Janvi, Dhamane, Amol D., Hines, Dionne M., Lee, Theodore, Rosenblatt, Lisa, Emir, Birol, Keshishian, Allison, Yuce, Huseyin, Luo, Xuemei
Publicado 2023

Comparative Clinical and Economic Outcomes Associated with Warfarin Versus Apixaban in the Treatment of Patients with Venous Thromboembolism in a Large U.S. Commercial Claims Datab...

por Guo, Jennifer D., Rajpura, Jigar, Hlavacek, Patrick, Keshishian, Allison, Sah, Janvi, Delinger, Rachel, Mu, Qiao, Mardekian, Jack, Russ, Cristina, Okano, Gary J., Rosenblatt, Lisa
Publicado 2020